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of Engagement
How B cells discriminate antigen-receptor-mediated
signals in development and navigate critical check-
points in adaptive immune responses remains poorly
resolved. In this issue of Immunity, Winslow et al.
(2006) conditionally ablate the main regulatory sub-
unit of the calcineurin phosphatase complex in B cells
to reveal both positive and negative influences on the
development of antibody responses and B cell
memory.
Antigen-specific receptors assembled during lympho-
cyte development need to be selected against self-
reactivity. Multiple lineage choices are also imprinted
based on the specificity of these antigen receptors and
the context of receptor engagement. How antigen re-
ceptors interpret these signals is of prime importance
to cell fate and serves to underpin the functional poten-
tial of adaptive immunity. Upon foreign antigen assault,
the right specificities need to be selected for ‘‘best fit’’
and clonally expanded in the dynamic effector-cell re-
sponse to antigen. Immune memory is another desired
set of outcomes that emerges after antigen engage-
ment. The rules that govern these selection events
and ultimately control cell fate remain critical unan-
swered issues in this field.
Calcineurin is a Ca2+/calmodulin-dependent serine-
threonine phosphatase that is expressed in a wide vari-
ety of tissues (Feske et al., 2003). Antigen receptor
crosslinking initiates a cascade of early intracellular ac-
tivation events that result in elevated intracellular Ca2+
(reviewed in detail, Gallo et al., 2006). Ca2+/calmodulin
then binds to the calcineurin complex that is comprised
of one catalytic subunit (one of three: Aa, Ab, or Ag) and
one regulatory subunit (one of two: Cnb1 or Cnb2), in-
ducing calcineurin phosphatase activity. The major tar-
gets of this phosphatase are the cytoplasmic compo-
nents of NFAT transcription factors (NFATc). Of the
four family members, NFATc1, c2, and c3 are expressed
in lymphocytes. Dephosphorylation of NFATc exposes
a nuclear localization signal, shuttling the NFATc into
the nucleus. In the nucleus, NFATc cooperates with
other transcription factors such as AP-1 (Fos/Jun) to en-
hance DNA binding and increase the specificity of tran-
scriptional control.
By using CD19-Cre-driven ablation of the Cnb1 regu-
latory subunit, Winslow et al. (2006) address the role of
the calcineurin complex in B cell development. Based
on cell surface phenotype, there were no apparent de-
fects in the levels of pro-B and pre-B cell intermediates
in the bone marrow. In the periphery, the number of B1
cells in the spleen and peritoneal cavity was signifi-
cantly decreased. B1 cell development occurs early in
ontogeny, establishing a phenotypically-distinct mature
B cell compartment with a distinguishable BCR reper-
toire. Changes in the numbers of these cells in the adultsuggest that NFATc plays a differential role (1) across
separable precursors in the bone marrow, (2) in the se-
lection of particular BCR specificities in the periphery
after development and/or (3) in maintenance of the B1
cell compartment. As there are residual B1 cells in this
model, an analysis of the BCR repertoire may help to re-
solve the precise level of the developmental defect.
In contrast to the B1 cell reduction, there were no
changes in the number of marginal zone (MZ) or follicu-
lar (FO) B cells in the spleens. The authors tested multi-
ple aspects of antigen-specific B cell tolerance induc-
tion based on previous reports of baseline nuclear
presence of NFATc in anergic B cells (Healy et al.,
1997). Surprisingly, there was no impact on tolerance
in the absence of Cnb1. There also appears to be little
impact on general events that shape the MZ versus
FO B cell compartment in the spleen, or an effect on
the tonic BCR signal that is required for mature B cell
survival in vivo. However, even though total numbers
are within normal limits, developmental programming
and/or the preimmune BCR repertoire composition
and assortment across mature B cell subsets may be al-
tered in ways that may impact immune function.
Figure 1 depicts central events in the development of
a T dependent (TD) B cell response with emphasis on
the checkpoints that regulate cell fate in each of three
separable phases (McHeyzer-Williams and McHeyzer-
Williams, 2005). Initiation of the adaptive response re-
quires activation of the innate immune system (Phase
I). Antigen-experienced pMHCII+ dendritic cells (DCs)
recruit naive pMHCII-specific Th cells in the T cell zones
of secondary lymphoid tissue (Checkpoint One). Th
clonal selection and expansion results in effector Th cell
differentiation and migration to the T-B borders. Naive B
cell priming is central to the initiation phase of TD B cell
responses that require Th cell regulation for B cell ex-
pansion and effector and memory B cell development.
In T independent (TI) responses, antigen priming can
lead to B cell selection, expansion, and the develop-
ment of antigen-specific plasma cells without the need
for cognate T cell help. Cnb1 deletion clearly and dra-
matically blocks BCR-induced proliferation and anti-
CD40-dependent plasma cell development in vitro (Win-
slow et al., 2006). However, LPS-driven proliferation and
its capacity to induce antibody production was com-
pletely intact. Nevertheless, when the authors used
TNP-LPS to drive a TI-1 response, they reveal a signifi-
cant increase in TNP-specific IgM and conclude that
NFAT transcriptional activity plays a negative regulating
role in keeping the TI response in check in vivo.
In TD responses, protein antigen-primed B cells must
present pMHCII complexes for cognate engagement by
effector Th cells (Phase II: Checkpoint Two). There is
a major bifurcation in B cell fate at this juncture. Clonal
expansion continues in the T cell zones and gives rise to
short-lived plasma cells that produce the early, germ-
line-encoded antibody response. Alternatively, B cell
expansion proceeds in the B cell zones as a precursor
to the germinal center (GC) reaction that controls the
development of B cell memory. It is plausible that the
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126Figure 1. Absence of CNB1 Impacts Several Checkpoints in TD B Cell Immunity
Initiation of the adaptive response (Phase I) requires presentation of pMHCII complexes by antigen-experienced DCs to pMHCII-specific naive
Th cells (Checkpoint One). Naive B cells must also uptake protein antigen and present surface pMHCII complexes to receive cognate help from
antigen-specific effector Th cells (Phase II: Checkpoint Two). B cell development bifurcates in this second phase with expansion of preplasma
cells in the T cell zones and production of short-lived plasma cells. Alternatively, clonal expansion in the B cell zones is the precursor of the ger-
minal center reaction (Phase III). Expansion is associated with BCR diversification by somatic hypermutation (SHM) in the dark zone of the GC
followed by selection of high-affinity variant BCR in the FDC-rich light zone of the GC that underpins affinity maturation. pMHCII-specific GC Th
cells also appear in the light zone and are thought to regulate the outcome of antigen-driven positive selection of GC B cells (Checkpoint Three).
Multiple cellular products of the GC reaction are depicted as stable subsets of the memory B cell compartment with differential bone marrow
homing propensity and separable capacity to respond to antigen recall. The measured impact of CNB1 in this TD B cell response pathway is
depicted on the schematic; however, its mechanism of action more likely involves the discrimination and integration of BCR signal strength
and costimulatory context at each of the developmental checkpoints involved in cell fate commitment.strength of the initial BCR signal differentially impacts
the initial naive B cell response to antigen and this intrin-
sically impacts cell fate. Additionally, different effector
Th cells may regulate alternate B cell fate.
In both TD models used by Winslow et al. (2005),
the early antibody response at day 7 is significantly re-
duced, suggesting a role for cnb1 and NFATc transcrip-
tional control in the short-lived plasma cell fate deci-
sion. Quantitative resolution of antigen binding B cells
would help to resolve the level of this defect. Hence,
whether loss of Cnb1 truncates expansion, differentia-
tion, or survival in this separate B cell development
pathway will be important to resolve.
The germinal center reaction promotes the evolution
of B cell memory (Phase III: Checkpoint Three). Clonal
expansion in the GC is associated with somatic diversi-
fication of BCR already selected with germ-line capacity
to bind the antigen. GC B cells expressing high-affinity
variant BCR can be rescued from apoptosis. In most
models, this latter antigen engagement occurs on follic-
ular dendritic cells (FDC) that can trap native antigen as
immune complexes in a complement- and FcR-depen-
dent manner. Recent studies demonstrate separable
mechanisms for the regulation of BCR diversification
and subsequent positive selection events. CD19 (Wang
and Carter, 2005) and CD45 (Huntington et al., 2006)
appear to differentially impact GC B cell fate by poten-
tially modifying BCR signals. Any positive selectionmechanism must discriminate BCR signal strength in
ways that will substantially impact GC B cell survival
and memory B cell subset differentiation. Furthermore,
pMHCII-specific GC Th cells also migrate to the FDC-
rich light zone, implying cognate control of memory B
cell fate.
Pre-GC induction and/or GC clonal expansion may be
negatively regulated by NFATc transcription. The large
GC observed (Winslow et al., 2006) are reminiscent of
the B cell phenotype in mice lacking AID (Muramatsu
et al., 2000), the cyclin dependent kinase (CDK) inhibitor
p18INK4c (Tourigny et al., 2002), and Blimp-1 (Shapiro-
Shelef et al., 2003). In the absence of AID, the larger
GC appears to be a consequence of hyperactive B cell
proliferation, implicating a negative feedback mecha-
nism after BCR diversification (Muramatsu et al.,
2000). The induction of cell cycle arrest appears to be
dependent CDK inhibitor p18INK4c and leads to large
GC with a lack of plasma cell differentiation (Tourigny
et al., 2002). Similarly, the large GC phenotype in the ab-
sence of Blimp-1 may also be related to dysregulated
cell cycle control (Shapiro-Shelef et al., 2003). However,
in the latter model, memory B cell development was
also defective, implicating a more complex role for this
transcriptional repressor in the evolution of cellular
events within the GC cycle. More extensive cellular
and BCR repertoire analysis of GC B cells and their
memory B cell progeny in the absence of Blimp-1,
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127p18, and Cnb1 will provide new insight into the control
of these critical selection events and their outcomes.
Winslow et al. (2006) also report significant decreases
in serum antibody later in the primary response and in
the memory response to antigen recall. These changes
indicate a diminution of long-lived plasma cells that are
another cellular product of the GC reaction. Therefore,
NFATc transcription may be involved in the initial com-
mitment to long-lived plasma cell fate or may influence
the expression of genes necessary for their survival long
term. Interestingly, the decreased memory response to
antigen recall also supports a role for NFATc transcrip-
tion in the production of memory B cells in the GC cycle.
It is possible that memory B cell fate relies on the dis-
crimination and integration of BCR signal strength,
and GC T cell help and differential NFATc transcription
may control this critical cell fate decision.
This powerful new model demonstrates the impact of
Cnb1 ablation on many facets of B cell responsiveness
in vivo. Primary B cell subset development is differen-
tially influenced with surprisingly no impact on the de-
velopment of B cell tolerance. TI and TD responses
are modified in a number of ways that reveal subtle
and substantial effects on the integration of BCR signals
in the determination of a variety of secondary B cell fate
decisions. The role of the calcineurin-NFAT pathway in
memory B cell development will certainly be important
to dissect more completely, and this new model pro-
vides a valuable new perspective to this endeavor.Immunity 24, February 2006 ª2006 Elsevier Inc. DOI 10.1016/j.immuni.2006
CD14: Chaperone or Matchmaker?
In this issue of Immunity, Lee et al. (2006) describe
a physical and functional relationship between Toll-
like receptor 3 (TLR3) and the pattern recognition pro-
tein CD14. In the presence of CD14, TLR3-mediated
signal transduction events are amplified.
CD14 has been known to be associated with TLRs for
many years. As a major lipopolysaccharide (LPS) bind-
ing protein, CD14 has a critical role in the mammalian
response to LPS. CD14 has also been demonstrated
to amplify many TLR2-specific responses. However,
many of us have assumed that in this ‘‘amplification’’
role, CD14, a glycosyl phosphadityl inositol anchored
protein, was interacting with TLR2 or TLR4 (both of
which are cell surface proteins) on the exterior mem-
brane of the cell. TLR3, on the other hand, which is ac-
tivated by double-stranded RNA, appears to function
primarily intracellularly (and is localized by Lee et al.
[2006] within the cell). This leads to a paradox. How
does an intracellular TLR such as TLR3 interact with
the extracellular pattern recognition protein CD14?Michael G. McHeyzer-Williams,1
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The GPI-anchored pattern recognition protein CD14
was initially characterized as a major LPS binding
protein (reviewed in Ziegler-Heitbrock and Ulevitch
[1993]). Mice without CD14 do not develop shock in re-
sponse to LPS challenge. Furthermore, the administra-
tion of monoclonal antibodies to CD14 can prevent sep-
tic shock in humans as well as mice. Interestingly, CD14
is present as a soluble protein in large quantities in the
serum of humans (and mice). Although the GPI anchor
of membrane CD14 contributes to its ability to enhance
cellular response to LPS, particularly at low concentra-
tions of ligand, the GPI linkage is dispensable. Thus,
both soluble CD14 as well as the cell-associated GPI-
anchored protein are able to enhance the cellular cyto-
kine response to LPS (Underhill, 2003; Ziegler-Heitbrock
and Ulevitch, 1993). Further, a CD14 construct in which
the GPI anchor was replaced with a bilayer spanning
transmembrane region also enhances the response to
LPS (Pugin et al., 1998). This is of particular interest be-
cause only the GPI-linked form of CD14 has been dem-
onstrated to reside in cholesterol-rich lipid microdo-
mains that contain src kinases and G proteins, which
play important roles in the response to LPS (Lentschat
et al., 2005; Solomon et al., 1998). For those of us who
